Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post Market Observational Study on the Use of CorMatrix® ECM® for Femoral Arterial Reconstruction

NCT02418156 is registered in ClinicalTrials.gov with Elutia Inc. as lead sponsor.

NCT NCT02418156
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02418156 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post Market Observational Study on the Use of CorMatrix® ECM® for Femoral Arterial Reconstruction
Lead sponsor
Elutia Inc.
Phase
Observational
Overall status
Completed
Start date
May 31, 2015
Completion date
March 31, 2018
Enrollment
38 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral vascular disease